%D8%AF%D9%88%D8%A7%D8%A1_%D9%85%D9%83%D8%A7%D9%81%D8%A6%D0%9B%D0%B5%D0%BA%D1%96-%D0%B0%D0%B4%D0%BF%D0%B0%D0%B2%D0%B5%D0%B4%D0%BD%D1%96%D0%BA%D1%96%E0%A6%9C%E0%A7%87%E0%A6%A8%E0%A7%87%E0%A6%B0%E0%A6%BF%E0%A6%95_%E0%A6%A1%E0%A7%8D%E0%A6%B0%E0%A6%BE%E0%A6%97%E0%A6%9C%E0%A7%87%E0%A6%A8%E0%A7%87%E0%A6%B0%E0%A6%BF%E0%A6%95_%E0%A6%A1%E0%A7%8D%E0%A6%B0%E0%A6%BE%E0%A6%97Medicament_gen%C3%A8ricGenerikumCyffur_generigGenerisk_l%C3%A6gemiddelGenerikum%CE%93%CE%B5%CE%BD%CF%8C%CF%83%CE%B7%CE%BC%CE%BF_%CF%86%CE%AC%CF%81%CE%BC%CE%B1%CE%BA%CE%BFGeneric_drugMedicamento_gen%C3%A9rico%D8%AF%D8%A7%D8%B1%D9%88%DB%8C_%DA%98%D9%86%D8%B1%DB%8C%DA%A9Rinnakkaisl%C3%A4%C3%A4keM%C3%A9dicament_g%C3%A9n%C3%A9rique%D7%AA%D7%A8%D7%95%D7%A4%D7%94_%D7%92%D7%A0%D7%A8%D7%99%D7%AA%E0%A4%B8%E0%A4%BE%E0%A4%AE%E0%A4%BE%E0%A4%A8%E0%A5%8D%E0%A4%AF_%E0%A4%A6%E0%A4%B5%E0%A4%BEGenerikus_gy%C3%B3gyszerObat_generikMedicinale_equivalente%E5%BE%8C%E7%99%BA%E5%8C%BB%E8%96%AC%E5%93%81%E0%B2%9C%E0%B3%86%E0%B2%A8%E0%B3%86%E0%B2%B0%E0%B2%BF%E0%B2%95%E0%B3%8D_%E0%B2%94%E0%B2%B7%E0%B2%A7%EC%A0%9C%EB%84%A4%EB%A6%AD_%EC%9D%98%EC%95%BD%ED%92%88Patentbr%C4%ABvais_medikaments%D0%93%D0%B5%D0%BD%D0%B5%D1%80%D0%B8%D1%87%D0%BA%D0%B8_%D0%BB%D0%B5%D0%BA%E0%B4%9C%E0%B5%86%E0%B4%A8%E0%B4%B1%E0%B4%BF%E0%B4%95%E0%B5%8D_%E0%B4%AE%E0%B4%B0%E0%B5%81%E0%B4%A8%E0%B5%8D%E0%B4%A8%E0%B5%81%E0%B4%95%E0%B5%BEUbat_generikGeneriek_geneesmiddelSynonympreparatLek_generycznyMedicamento_gen%C3%A9ricoMedicament_generic%D0%94%D0%B6%D0%B5%D0%BD%D0%B5%D1%80%D0%B8%D0%BAGeneric_drugGenerick%C3%BD_liekGeneri%C4%8Dno_zdraviloGeneriska_l%C3%A4kemedel%E0%B0%9C%E0%B0%A8%E0%B0%B0%E0%B0%BF%E0%B0%95%E0%B1%8D_%E0%B0%AE%E0%B0%82%E0%B0%A6%E0%B1%81%E0%B0%B2%E0%B1%81Jenerik_ila%C3%A7%D0%94%D0%B6%D0%B5%D0%BD%D0%B5%D1%80%D0%B8%D0%BA
about
sameAs
P1889
P2283
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimodThe Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?Generic versus brand-name drugs used in cardiovascular diseasesWhat do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugsQuality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic reviewGeneric development of topical dermatologic products, Part II: quality by design for topical semisolid productsDefinition and Classification of Generic Drugs Across the WorldBehaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic reviewA Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent OriginatorsPotential Clinical and Economic Impact of Switching Branded Medications to Generics.Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancerA review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.Ontario's plunging price-caps on generics: deeper dives may drown some drugs.Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.A reappraisal of generic bisphosphonates in osteoporosis.A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?Perceptions of generic medication in the general population, doctors and pharmacists: a systematic reviewBiosimilars in Developed and Developing East and Southeast Asian Countries: Japan, South Korea, and Malaysia-Overview, Evolution, and Regulations Assessment.Requirements for generic anti-epileptic medicines: a regulatory perspective.The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review.Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis.Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.Overview of the European Medicines Agency's Development of Product-Specific Bioequivalence Guidelines.
P921
Q26740235-6C96514B-CC6C-405F-AE5D-8CDFEE699AC0Q26767337-EED748E4-7BC2-4C07-975A-318FC05C42A4Q26775920-B595A128-1D80-4149-9B79-0486514747B5Q26801726-497DFAED-3C6A-4DA9-AED6-280345792C0AQ26824973-4CF5B88D-91AA-4F82-AA4B-E5F3132C53BDQ26829800-D995A2B9-E728-4BCA-9969-3C1C1C4C363AQ26830753-E0E8F96B-1AB8-4B20-B828-50227FD721F5Q26866161-6A5DB5C3-E798-43A6-B2A5-FAD8343B5C91Q27007494-39F4C6EF-90D4-4C15-BEC9-AF38ED9046D1Q33637817-5BD83062-1399-4E57-BB0E-8D10337B5EF4Q34104391-A76191B4-7540-404B-AEB6-A80BF4353F18Q34536861-C1EA551E-5984-4E6E-A879-741609F44ACDQ35496895-53A0777D-8F47-4D09-97D3-1FA1D91917C0Q35547234-6FC7BF7F-38DF-422C-AA29-B32321E98887Q35644168-96843E3B-E211-4DDF-8DA3-9AF07F08B68DQ35901619-78F0CB7F-9326-4E00-BDB6-C8C6458DC858Q36374308-A9323390-7FEA-4C61-96E2-B0645AA5743FQ36880713-C3770F8B-72C5-41F9-962E-B813424E9242Q37428755-58B8FDEB-8852-4227-96E2-AD95217A356BQ38532357-20D84D8E-F928-467C-BABA-F1B3DC72DCB3Q38535040-723A21BF-AF07-4226-85F0-2D6E87956B03Q38636620-C53DFE89-8521-42E6-8B12-ABF9D5E6EA3EQ49889501-9C529F2B-905F-4E7A-BE7F-7A5CF06AF4EAQ50107343-7D2F869A-D396-4983-80CE-449C2203FF7B
P921
description
Medikament, Nachahmerpräparat
@de
Médicament non-breveté
@fr
cyffur fferyllol sy'n cyfateb ...... ansawdd, perfformiad a defnydd
@cy
medicinale che, in seguito a s ...... ispetto ad un altro medicinale
@it
pharmaceutical drug that is eq ...... performance, and intended use
@en
танныя адпаведнікі лекаў першаснай распрацоўкі
@be-tarask
name
Generický liek
@sk
Generikum
@de
Generikus gyógyszer
@hu
Generisk lægemiddel
@da
Generično zdravilo
@sl
Medicament generic
@ro
Obat generik
@id
Rinnakkaislääke
@fi
Synonympreparat
@nb
Thuốc gốc
@vi
type
label
Generický liek
@sk
Generikum
@de
Generikus gyógyszer
@hu
Generisk lægemiddel
@da
Generično zdravilo
@sl
Medicament generic
@ro
Obat generik
@id
Rinnakkaislääke
@fi
Synonympreparat
@nb
Thuốc gốc
@vi
altLabel
Biogénérique
@fr
Bistveno podobno zdravilo
@sl
EFG
@ca
EFG
@es
Farmaci equivalenti
@it
Farmaci generici
@it
Farmaco equivalente
@it
Farmaco generico
@it
Geneerinen lääke
@fi
Geneerinen valmiste
@fi
prefLabel
Generický liek
@sk
Generikum
@de
Generikus gyógyszer
@hu
Generisk lægemiddel
@da
Generično zdravilo
@sl
Medicament generic
@ro
Obat generik
@id
Rinnakkaislääke
@fi
Synonympreparat
@nb
Thuốc gốc
@vi
P227
P349
P486
P6366
P646
P1296
P1417
topic/generic-drug
P1552
P1889
P227
P3219
medicaments-generiques
P3417
Generic-Drugs
P349
P3827
generic-drugs
P486
P6366
2776396487